Bath & Body Works, Inc. (NYSE:BBWI) Receives Average Rating of "Hold" from Analysts

Key Points

• Analyst consensus "Hold": Seventeen analysts cover BBWI (14 hold, 3 buy) with an average 1‑year price target of $23.00.
• Q results topped estimates: The company reported $2.05 EPS versus $1.77 expected and $2.72B revenue versus $2.59B expected, though revenue was down 2.3% year‑over‑year; management set FY2026 guidance of $2.40–$2.65 EPS (analysts ~2.6 EPS).
• Attractive income profile: Bath & Body Works pays a $0.20 quarterly dividend ($0.80 annual), yielding about 4.2% with a payout ratio of 25.4%.

Bath & Body Works, Inc. (NYSE:BBWI - Get Free Report) has been assigned a consensus rating of "Hold" from the seventeen ratings firms that are presently covering the firm, MarketBeat reports. Fourteen research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year target price among brokers that have updated their coverage on the stock in the last year is $23.00.

Several equities research analysts have commented on the stock. Citigroup cut shares of Bath & Body Works from a "buy" rating to a "neutral" rating and boosted their price target for the stock from $21.00 to $25.00 in a research report on Tuesday, February 17th. UBS Group boosted their price target on shares of Bath & Body Works from $21.00 to $22.00 and gave the stock a "neutral" rating in a research report on Monday, February 23rd. Telsey Advisory Group boosted their price target on shares of Bath & Body Works from $23.00 to $25.00 and gave the stock a "market perform" rating in a research report on Thursday, March 5th. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Bath & Body Works in a report on Monday, April 20th. Finally, Zacks Research raised shares of Bath & Body Works from a "strong sell" rating to a "hold" rating in a report on Tuesday, January 20th.

Bath & Body Works Price Performance

Shares of NYSE:BBWI opened at $19.20 on Friday. The company's 50-day moving average price is $19.89 and its two-hundred day moving average price is $21.13. Bath & Body Works has a one year low of $14.27 and a one year high of $34.66. The stock has a market capitalization of $3.87 billion, a PE ratio of 6.09, a price-to-earnings-growth ratio of 1.92 and a beta of 1.43.

Bath & Body Works (NYSE:BBWI - Get Free Report) last issued its quarterly earnings results on Wednesday, March 4th. The company reported $2.05 EPS for the quarter, topping the consensus estimate of $1.77 by $0.28. Bath & Body Works had a net margin of 8.90% and a negative return on equity of 45.60%. The firm had revenue of $2.72 billion for the quarter, compared to analysts' expectations of $2.59 billion. During the same period in the previous year, the firm posted $2.09 EPS. The company's revenue for the quarter was down 2.3% on a year-over-year basis. Bath & Body Works has set its Q1 2026 guidance at 0.240-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. On average, analysts anticipate that Bath & Body Works will post 2.6 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 6th. Stockholders of record on Friday, February 20th were issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a dividend yield of 4.2%. The ex-dividend date of this dividend was Friday, February 20th. Bath & Body Works's dividend payout ratio is presently 25.40%.

Institutional Investors Weigh In On Bath & Body Works

A number of institutional investors and hedge funds have recently modified their holdings of BBWI. Royal Bank of Canada raised its holdings in shares of Bath & Body Works by 92.8% in the 1st quarter. Royal Bank of Canada now owns 59,877 shares of the company's stock valued at $1,815,000 after purchasing an additional 28,815 shares during the period. Goldman Sachs Group Inc. raised its holdings in shares of Bath & Body Works by 15.7% in the 1st quarter. Goldman Sachs Group Inc. now owns 645,970 shares of the company's stock valued at $19,586,000 after purchasing an additional 87,529 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Bath & Body Works by 7.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 562,757 shares of the company's stock valued at $17,063,000 after purchasing an additional 36,684 shares during the period. Intech Investment Management LLC bought a new stake in shares of Bath & Body Works in the 1st quarter valued at about $1,155,000. Finally, Geneos Wealth Management Inc. raised its holdings in shares of Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company's stock valued at $35,000 after purchasing an additional 801 shares during the period. 95.14% of the stock is owned by institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.